Literature DB >> 2673590

Failure of Mycobacterium leprae soluble antigens to suppress delayed-type hypersensitivity reaction to tuberculin.

P E Fine1, P J Gruer, N Maine, J M Ponnighaus, R J Rees, J L Stanford.   

Abstract

In order to test a published claim that the inclusion of Mycobacterium leprae antigens with a tuberculin skin test reagent can suppress delayed-type hypersensitivity (DTH) to tuberculin in both paucibacillary and multibacillary leprosy cases, 109 leprosy cases and 104 non-leprosy controls were skin-tested simultaneously with tuberculin with and without M. leprae soluble antigens. Tests were randomized between arms and carried out double-blind. There was a clear tendency for larger DTH responses with the combined tuberculin plus M. leprae antigen than with tuberculin alone in paucibacillary leprosy cases and in non-leprosy controls. No evidence for M. leprae antigen-mediated suppression of DTH was observed in any group. It is unclear whether the difference between the results reported here, which were obtained in Malawi, and those in the published literature which were obtained in India, is attributable to geographic differences in important biological variables or to differences in the experimental protocols. The need for methodological rigour in skin-test studies is stressed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2673590      PMCID: PMC1541994     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  12 in total

1.  Lepromin-induced suppressor cells in patients with leprosy.

Authors:  V Mehra; L H Mason; J P Fields; B R Bloom
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

2.  The Lepra Evaluation Project (LEP), an epidemiological study of leprosy in Northern Malaŵi. I. Methods.

Authors:  J M Ponninghaus; P E Fine; L Bliss; I J Sliney; D J Bradley; R J Rees
Journal:  Lepr Rev       Date:  1987-12       Impact factor: 0.537

3.  The Lepra Evaluation Project (LEP), an epidemiological study of leprosy in northern Malaŵi. II: Prevalence rates.

Authors:  J M Ponnighaus; P E Fine; N Maine; L Bliss; M Kalambo; I Ponnighaus
Journal:  Lepr Rev       Date:  1988-06       Impact factor: 0.537

4.  Certainty levels in the diagnosis of leprosy.

Authors:  J M Ponnighaus; P E Fine; L Bliss
Journal:  Int J Lepr Other Mycobact Dis       Date:  1987-09

5.  The use of a sonicate preparation of Mycobacterium tuberculosis (new tuberculin) in the assessment of BCG vaccination.

Authors:  J L Stanford; E Lema
Journal:  Tubercle       Date:  1983-12

6.  Lymphocyte suppression in leprosy induced by unique M. leprae glycolipid.

Authors:  V Mehra; P J Brennan; E Rada; J Convit; B R Bloom
Journal:  Nature       Date:  1984 Mar 8-14       Impact factor: 49.962

Review 7.  Suppressor cell activity and phenotypes in the blood or tissues of patients with leprosy.

Authors:  T H Rea
Journal:  Clin Exp Immunol       Date:  1983-11       Impact factor: 4.330

8.  Induction of delayed-type hypersensitivity to Mycobacterium leprae in healthy individuals.

Authors:  A H Smelt; R J Rees; F Y Liew
Journal:  Clin Exp Immunol       Date:  1981-06       Impact factor: 4.330

Review 9.  Immunological unresponsiveness in leprosy.

Authors:  B R Bloom; V Mehra
Journal:  Immunol Rev       Date:  1984-08       Impact factor: 12.988

10.  Natural suppressor cells in human leprosy: the role of HLA-D-identical peripheral lymphocytes and macrophages in the in vitro modulation of lymphoproliferative responses.

Authors:  I Nath; J J Van Rood; N K Mehra; M C Vaidya
Journal:  Clin Exp Immunol       Date:  1980-11       Impact factor: 4.330

View more
  1 in total

1.  Changes in cellular response to mycobacterial antigens and cytokine production patterns in leprosy patients during multiple drug therapy.

Authors:  V T Trao; P L Huong; A T Thuan; D D Anh; D D Trach; G A Rook; E P Wright
Journal:  Immunology       Date:  1998-06       Impact factor: 7.397

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.